Growth Metrics

Quest Diagnostics (DGX) Other Non-Current Liabilities (2016 - 2026)

Quest Diagnostics has reported Other Non-Current Liabilities over the past 18 years, most recently at $1.0 billion for Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 11.45% to $1.0 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.0 billion through Mar 2026, up 11.45% year-over-year, with the annual reading at $957.0 million for FY2025, 2.03% up from the prior year.
  • Other Non-Current Liabilities was $1.0 billion for Q1 2026 at Quest Diagnostics, up from $957.0 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $1.0 billion in Q1 2026 and troughed at $6.0 million in Q2 2024.
  • The 5-year median for Other Non-Current Liabilities is $874.0 million (2023), against an average of $772.7 million.
  • Biggest five-year swings in Other Non-Current Liabilities: plummeted 93.18% in 2024 and later skyrocketed 14733.33% in 2025.
  • Tracing DGX's Other Non-Current Liabilities over 5 years: stood at $812.0 million in 2022, then rose by 7.88% to $876.0 million in 2023, then increased by 7.08% to $938.0 million in 2024, then grew by 2.03% to $957.0 million in 2025, then increased by 6.79% to $1.0 billion in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $1.0 billion, $957.0 million, and $982.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.